These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20587929)

  • 21. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M; Guarnaccia M; Alon J; Wiley J
    Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progestogen-only injectable contraceptive: experience of women in Osogbo, southwestern Nigeria.
    Adeyemi AS; Adekanle DA
    Ann Afr Med; 2012; 11(1):27-31. PubMed ID: 22199044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current concepts regarding use of DMPA.
    Kaunitz AM
    J Reprod Med; 2002 Sep; 47(9 Suppl):785-9. PubMed ID: 12380407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progestogen-only injectable contraceptive: Acceptor prevalence and client experience at Sagamu, Nigeria.
    Akadri AA; Odelola OI
    Niger Postgrad Med J; 2017; 24(3):178-181. PubMed ID: 29082908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
    Aktun H; Moroy P; Cakmak P; Yalcin HR; Mollamahmutoglu L; Danisman N
    Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Birth intervals and injectable contraception in sub-Saharan Africa.
    Ngianga-Bakwin K; Stones RW
    Contraception; 2005 May; 71(5):353-6. PubMed ID: 15854636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects.
    Basnayake S; Thapa S
    Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors determining the choice of contraceptive methods at the Family Planning Clinic, University College Hospital, Ibadan, Nigeria.
    Konje JC; Oladini F; Otolorin EO; Ladipo OO
    Br J Fam Plann; 1998 Oct; 24(3):107-10. PubMed ID: 9855717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
    Ertopçu K; Inal MM; Ozelmas I
    Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):1-5. PubMed ID: 16036290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depo-provera: clinical evaluation.
    Mukherjea M
    Contracept Deliv Syst; 1981 Jul; 2(3):259-69. PubMed ID: 12278913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Socio-demographic characteristics of family planning clients and their possible influence on contraception in Malawi.
    Lema VM; Mtimavalye LA; Msiska FS
    East Afr Med J; 1998 Jan; 75(1):41-6. PubMed ID: 9604534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contraceptive choices of women in rural Southeastern Nigeria.
    Chigbu B; Onwere S; Aluka C; Kamanu C; Okoro O; Feyi-Waboso P
    Niger J Clin Pract; 2010 Jun; 13(2):195-9. PubMed ID: 20499755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injectable contraception.
    Mishell DR
    J Reprod Med; 2002 Sep; 47(9 Suppl):777-9. PubMed ID: 12380405
    [No Abstract]   [Full Text] [Related]  

  • 34. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR; Hammond N; Brown HE; Roddy ME
    J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of hormonal contraceptives in an institutional setting: reasons for use, consent and safety in women with psychiatric and intellectual disabilities.
    Egan TM; Siegert RJ; Fairley NA
    N Z Med J; 1993 Aug; 106(961):338-41. PubMed ID: 8341476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Same-day administration of depot-medroxyprogesterone acetate injection: a retrospective chart review.
    Balkus J; Miller L
    Contraception; 2005 May; 71(5):395-8. PubMed ID: 15854642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prolonged use of medroxyprogesterone acetate for contraception].
    Pena Delgado J; Aleman Herrera M; Baez Reyes A
    Sem Med Mex; 1981 Jun; 98(11):331-50. PubMed ID: 12279435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depot-medroxyprogesterone acetate contraception use among Salvadoran women: an in-depth analysis of attitudes and experiences.
    Cremer M; Ditzian L; April A; Peralta E; Klausner D; Podolsky R; Dierking E
    J Womens Health (Larchmt); 2011 Nov; 20(11):1751-6. PubMed ID: 21823919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting contraceptive options.
    Kaunitz AM
    Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.